2018 State of Specialty
Spend and Trend Report

The second annual State of Specialty Specialty Spend and Trend report analyzes specialty drug utilization and spending. Our Artemetrx® platform integrates pharmacy and medical claims data to the individual patient level, enabling us to present within this report a complete and unique view of specialty costs across all benefits.

Download the report today! 

Download |

 



WEBINAR RECORDING: PSG'S EXPERTS REVIEW AND ANALYZE THE RESULTS OF THE REPORT

WATCH NOW! |

Who is PSG?

PSG is the leading pharmacy intelligence and technology company providing
cutting-edge drug cost management solutions.

Benefit Consulting

In the increasingly complex world of drug management, hospital plan sponsors need an impartial advisor with the expertise to drive channel transparency and maximize financial savings. PSG’s consulting team offers deep industry knowledge to develop innovative best-in-class pharmacy benefit programs on behalf of our clients and their employees.

– Contract Optimization
– Benefit Strategy
– Audit and Oversight



Data and Analytics

Artemetrx is PSG’s robust data and analytics platform that drives measurable financial results through a sophisticated, integrated pharmacy and medical claims dataset. Our web-based solutions provide dashboards, reports, and tools delivering transparency and actionable interventions to improve program performance.

Benefit Performance and Benchmarking
Specialty Drug Management



340B Solutions

PSG offers a highly differentiated suite of solutions enabling you to expertly manage your 340B program. Backed by our sophisticated qualification engine, our split-billing and contract pharmacy solutions lead the industry in compliance while maximizing savings. PSG also offers robust 340B consulting services that include traditional compliance and audit support as well as program optimization and procurement.



Industry Intelligence

PBMI is recognized as the leading, independent industry voice offering market-defining research, education and leading-edge industry events. Our insights enable evidence-based, actionable decision making in a complex and evolving pharmaceuticals marketplace.